Position in OGN
as of Jun 30, 2026
· filed Jul 7, 2026
Position Value
$433
+$302 QoQ
Shares Held
32
+45.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#527
of 626 holders
Holding Since
Mar 2024
10 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in OGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Central Pacific Bank - Trust Division holds $21,867,179 across 13 Drug Manufacturers - General names. OGN ranks #13 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
7,222 | $8,662,284 | |
| 2 | JNJ |
Johnson & Johnson
|
16,537 | $4,199,901 | |
| 3 | MRK |
Merck & Co., Inc.
|
16,924 | $2,174,733 | |
| 4 | ABBV |
AbbVie Inc.
|
5,766 | $1,450,956 | |
| 5 | GILD |
Gilead Sciences, Inc.
|
9,589 | $1,211,474 | |
| 6 | AZN |
Astrazeneca PLC
|
5,179 | $982,041 | |
| 7 | GSK |
GSK plc
|
13,813 | $724,077 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
12,054 | $694,551 |
All Filings in OGN
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $433 | 32 | Shares | Defined | 2026-07-07 | |
| 2026-03-31 | $131 | 22 | Shares | Defined | 2026-04-08 | |
| 2025-12-31 | $157 | 22 | Shares | Defined | 2026-01-07 | |
| 2025-09-30 | $234 | 22 | Shares | Defined | 2025-10-02 | |
| 2025-06-30 | $212 | 22 | Shares | Defined | 2025-07-02 | |
| 2025-03-31 | $327 | 22 | Shares | Defined | 2025-04-03 | |
| 2024-12-31 | $373 | 25 | Shares | Defined | 2025-01-03 | |
| 2024-09-30 | $478 | 25 | Shares | Defined | 2024-10-02 | |
| 2024-06-30 | $517 | 25 | Shares | Defined | 2024-07-30 | |
| 2024-03-31 | $470 | 25 | Shares | Defined | 2024-05-02 | |
| No filing history on record for this holder in this stock. | ||||||